A First-in-Class Immunotherapy that Trains Your Immune System to Fight Your Cancer
Immunocine offers a personalized immunotherapy that utilizes a proprietary Double Loaded dendritic cell technology to help your immune system detect and fight cancer. Our approach combines scientific rigor with personalized immunotherapy to address cancer as an immunological disorder.
A Revolutionary Approach to Cancer Treatment
Driven by our own academic breakthrough, we train the immune system to attack cancer by precisely loading dendritic cells with both mRNA and proteins — at the right time and in the right place.
Dendritic cells alone are not enough; they must be used in a scientifically precise way. This science-first approach is redefining immunotherapy and may help change cancer outcomes for good.
Fully Leverage
the Immune System
Educate
Activate
Eliminate
Complete
Our Dendritic Cell Treatment initiates a complete Immune Response against your cancer cells.
This top-down approach avoids the unspecific and ineffective targeting of other Immunotherapies.
Natural
Our Dendritic Cell Treatment does not introduce any foreign compounds or genetically modified cells into the body.
By using your body’s own cells, our treatment significantly reduces the risk of side effects.
Ongoing
Our Dendritic Cell Treatment fully activates the Immune System and therefore continues after patients have received their last treatment.
This Immunological Memory can make it much harder for the cancer to return.
We Treat Patients, Not Just Diseases
Behind every treatment is a human story. Many of our patients come to us during or after standard-of-care treatments that delivered limited or no results. What they find at Immunocine is a new path: rooted in science, delivered with compassion, and designed specifically for them. These are real-world, life-changing outcomes.
“My doctor told me I have stage four and that I don’t have much time left. Now I have zero signs of cancer.”
— Brian B.
Stage 4 Bladder Cancer
Randy was diagnosed with Stage 4 colon cancer just two years after a clean scan. He underwent major surgery and HIPEC treatment, but his survival odds remained daunting, leading him to discover Immunocine.
Diagnosed with a rare kidney cancer, Justin faced a devastating prognosis. After multiple recurrences, he turned to the IDCT. Now, his tumor markers have plummeted, giving him a future with his family.
See if the Immunocine Dendritic Cell Treatment is Right for You or a Loved One
If you meet the baseline eligibility requirements listed below, we can conduct an intro call and then a complimentary medical evaluation to determine if our treatment is right for you.
Solid Tumors
While we are constantly expanding our capabilities, right now we only treat patients with solid tumors that can be biopsied by our medical staff. Blood malignancies, such as Leukemia, cannot be treated at this time.
Stable Immune System
For any immunotherapy to be successful, a patient needs to have a stable, functioning immune system. Patients with immune deficiencies and other conditions may not qualify for treatment until normal activity is restored.
Ability to Travel
Some medical conditions and other factors may prevent patients from traveling. Our treatment is administered exclusively at our facility in Cancún, Mexico. If you are unable to travel, you will not be able to receive our treatment.
Six-Week Treatment
Our treatment protocol requires three separate treatments, each two weeks apart. Patients can either choose to stay in Cancun for six weeks or visit twice for two weeks at a time.
Redefining Medical Tourism with a World-Class Staff and Facilities in Cancun, Mexico
Our facility maintains cGMP and ISO certifications in compliance with Mexican healthcare facility requirements and operates under all applicable local and federal Mexican regulations. Based in Cancun, our team will take care of you from arrival to departure.
